Jazz Pharmaceuticals (JAZZ) PT Raised to $235 at Barclays

February 24, 2021 4:36 AM EST
Get Alerts JAZZ Hot Sheet
Price: $169.79 --0%

Rating Summary:
    32 Buy, 3 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 17 | Down: 10 | New: 10
Trade Now! 
Join SI Premium – FREE
Barclays analyst Balaji Prasad raised the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $235.00 (from $233.00) while maintaining a Overweight rating.

You May Also Be Interested In





Related Categories

Analyst PT Change